Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 18, 8-hydroxyquinoline, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2022’;
in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2022’;
in the sixth column, expiration of approval, of row 276, Chlormequat, the date is replaced by ‘30 November 2022’;
in the sixth column, expiration of approval, of row 278, Propaquizafop, the date is replaced by ‘30 November 2022’;
in the sixth column, expiration of approval, of row 279, Quizalofop-P-ethyl and Quizalofop-P-tefuryl, the date is replaced by ‘30 November 2022’;
in the sixth column, expiration of approval, of row 284, Dimethachlor, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 285, Etofenprox, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 287, Penconazole, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 288, Tri-allate, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 293, Tetraconazole, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 295, Paraffin oil, the date is replaced by ‘31 December 2022’;
in the sixth column, expiration of approval, of row 299, 2-phenylphenol (including its salts such as the sodium salt), the date is replaced by ‘31 December 2022’.